About
Home / About
About Us
We do our best to realize the human dream of a healthy and beautiful life and satisfy customer's needs.
GentriBIO is a bio venture company that wants to grow into a leading company in the life science field with the goal of realizing the best satisfaction for customer needs and providing a healthy life.
We are developing a new synthetic active drug (NSAD), the samll molecular weight compound, based on natural ingredients as an effective dual-effect anticancer drug that can control blood sugar and cancer therapy. In addition, we are spurring the development of biosimilars for diabetes treatment as an insulin replacement drug and blood sugar control supplements to prevent diabetes.
Goal
Pursuing leading companies in the field of life science
Value
Realize human dreams about health and beauty
Vision
Human value realization, aspiration, and human dignity
History
Since 2019
2022
Aug.
- Confirmation of R&D Type Venture Company
May.
- Registered the Patent for Natural Complex for Itch Relief & Wound Healing in US
- Patent Application for New Synthetic Active Drug with Dual Efficacy for Anti-cancer & anti-diabetes
Mar.
- Signed Contract for Business in ECOWAS Countries, Africa
Jan.
- Accredited as an Corporate Affiliated Research Institute
- Confirmation of R&D Type Venture Company
May.
- Registered the Patent for Natural Complex for Itch Relief & Wound Healing in US
- Patent Application for New Synthetic Active Drug with Dual Efficacy for Anti-cancer & anti-diabetes
Mar.
- Signed Contract for Business in ECOWAS Countries, Africa
Jan.
- Accredited as an Corporate Affiliated Research Institute
2021
Dec.
- EzPid™ One-step COVID-19 Detection Kit Commercialization
Nov.
- Performed two R&D Project with the Grant of Ministry of SMEs
- Registered the Domestic Patent for Natural Complex for Itch Relief & Wound Healing
Oct.
- Pre-clinical Trial for New Anti-diabetic Drug & Wound Healing Ointment
Aug.
- Development of New Synthetic Active Drug for Anti-cancer & Anti-diabetes
- ViPuri™ Viral RNA Extraction Kit CE IVD authentication (IE/CA01/R/IV/1578/43242)
Jan.
- ISO 13485:2016 (MK000139) Certification
- EzPid™ One-step COVID-19 Detection Kit Commercialization
Nov.
- Performed two R&D Project with the Grant of Ministry of SMEs
- Registered the Domestic Patent for Natural Complex for Itch Relief & Wound Healing
Oct.
- Pre-clinical Trial for New Anti-diabetic Drug & Wound Healing Ointment
Aug.
- Development of New Synthetic Active Drug for Anti-cancer & Anti-diabetes
- ViPuri™ Viral RNA Extraction Kit CE IVD authentication (IE/CA01/R/IV/1578/43242)
Jan.
- ISO 13485:2016 (MK000139) Certification
2020
Dec.
- Manufacturing & Export license for In Vitro Diagnostic Medical Devices
Nov.
- Selected as an Excellent Startup Company for in vitro Diagnostics
July.
- Lowering Blood Sugar Functional Vitamin, VitaGlu™ Launching
May.
- Signed Overseas Export Contract for COVID-19 Diagnostic kits
- Signed a Contract with Venture Capital DHJ Holdings (Canada)
Apr.
- Selected as an Export Support Infrastructure Project by Korea SMEs And Startups Agency
- Confirmation of Venture Business by Technology Guarantee Fund & Technology Evaluation Excellent Certified Company
Mar.
- Direct Export of OEM-made Cosmetics to US Distribution Channels
Feb.
- Recombinant Insulin Analogs Preclinical Trials for Diabetes Treatment (in progressing)
- Manufacturing & Export license for In Vitro Diagnostic Medical Devices
Nov.
- Selected as an Excellent Startup Company for in vitro Diagnostics
July.
- Lowering Blood Sugar Functional Vitamin, VitaGlu™ Launching
May.
- Signed Overseas Export Contract for COVID-19 Diagnostic kits
- Signed a Contract with Venture Capital DHJ Holdings (Canada)
Apr.
- Selected as an Export Support Infrastructure Project by Korea SMEs And Startups Agency
- Confirmation of Venture Business by Technology Guarantee Fund & Technology Evaluation Excellent Certified Company
Mar.
- Direct Export of OEM-made Cosmetics to US Distribution Channels
Feb.
- Recombinant Insulin Analogs Preclinical Trials for Diabetes Treatment (in progressing)
2019
Dec.
- Health Functional Food Import Business License Registration
Nov.
- Signed MOU for Joint Research on Diabetes New Drug Development with Pharmzens Inc., USA
Sep.
- Established the GentriBIO Inc.
- Health Functional Food Import Business License Registration
Nov.
- Signed MOU for Joint Research on Diabetes New Drug Development with Pharmzens Inc., USA
Sep.
- Established the GentriBIO Inc.
Certification
Certificates & Patents
R&D Type Venture Company
Patent US11337942B2
Poland R.349116
Research Institute
ISO 13485:2016
Patent 10-2325178
Design 30-1126583
Trade Mark 40-1769254
Trade Mark 40-1635284
Trade Mark 40-1685923